Yahoo Web Search

Search results

    • Civil fraud

      • NEW YORK (Reuters) - Walgreens Boots Alliance Inc will pay $269.2 million to settle two whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs over a decade, the U.S. Department of Justice said on Tuesday.
  1. People also ask

  2. Jan 22, 2019 · The first settlement, approved on January 16, 2019, by U.S. District Judge Paul A. Crotty and unsealed today, requires WALGREENS to pay $209.2 million to resolve allegations that it improperly billed Medicare, Medicaid, and other federal healthcare programs for hundreds of thousands of insulin pens it knowingly dispensed to program ...

  3. Jan 22, 2019 · The pharmacy chain will pay $209.2 million to resolve claims it improperly billed Medicare, Medicaid and other federal programs from 2006 to 2017 for hundreds of thousands of insulin pens it ...

  4. Jan 22, 2019 · NEW YORK, Jan 22 (Reuters) - Walgreens Boots Alliance Inc will pay $269.2 million to settle two whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs...

  5. Jan 23, 2019 · Walgreens Boots Alliance Inc will pay $269.2 million to settle two whistleblower lawsuits accusing it of civil fraud for overbilling federal healthcare programs over a decade, the U.S. Department of Justice said on Tuesday.

  6. Jan 22, 2019 · The Illinois-based pharmacy chain was accused of improperly billing Medicare, Medicaid, and other federal healthcare programs for insulin pens that Walgreens "knowingly dispensed" to federal beneficiaries who did not need them. The company agreed to pay $209.2 million to resolve the claims.

  7. Jan 22, 2019 · Walgreens Boots Alliance Inc will pay $269.2 million to the United States and state governments to settle two civil healthcare fraud lawsuits, the U.S. Department of Justice said on Tuesday.

  8. Jan 22, 2019 · Walgreens Boots Alliance Inc. agreed to pay $269.2 million to settle U.S. claims that the drugstore chain defrauded a federally-funded health-care program over insulin drugs and a consumer-discount initiative. The two settlements, announced Jan. 22, cover allegations over improper billing.

  1. People also search for